121 related articles for article (PubMed ID: 1383257)
1. Immune response to GOR, a marker for non-A, non-B hepatitis and its correlation with hepatitis C virus infection.
Mehta SU; Mishiro S; Sekiguchi K; Leung T; Dawson GJ; Pendy LM; Peterson DA; Devare SG
J Clin Immunol; 1992 May; 12(3):178-84. PubMed ID: 1383257
[TBL] [Abstract][Full Text] [Related]
2. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process.
Mishiro S; Hoshi Y; Takeda K; Yoshikawa A; Gotanda T; Takahashi K; Akahane Y; Yoshizawa H; Okamoto H; Tsuda F
Lancet; 1990 Dec; 336(8728):1400-3. PubMed ID: 1701012
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.
Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S
Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249
[TBL] [Abstract][Full Text] [Related]
4. Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity.
Quiroga JA; Pardo M; Navas S; Martín J; Carreño V
J Infect Dis; 1996 Feb; 173(2):300-5. PubMed ID: 8568289
[TBL] [Abstract][Full Text] [Related]
5. An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen.
Mishiro S; Takeda K; Hoshi Y; Yoshikawa A; Gotanda T; Itoh Y
Autoimmunity; 1991; 10(4):269-73. PubMed ID: 1723001
[TBL] [Abstract][Full Text] [Related]
6. Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease.
Hayashi J; Nakashima K; Kishihara Y; Ohmiya M; Yoshimura E; Hirata M; Kashiwagi S
J Infect; 1993 May; 26(3):287-94. PubMed ID: 7685043
[TBL] [Abstract][Full Text] [Related]
7. In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C.
Löhr HF; Gerken G; Michel G; Braun HB; Meyer zum Büschenfelde KH
Gastroenterology; 1994 Nov; 107(5):1443-8. PubMed ID: 7523227
[TBL] [Abstract][Full Text] [Related]
8. Detection of hepatitis C viral sequences in non-A, non-B hepatitis.
Weiner AJ; Kuo G; Bradley DW; Bonino F; Saracco G; Lee C; Rosenblatt J; Choo QL; Houghton M
Lancet; 1990 Jan; 335(8680):1-3. PubMed ID: 1967327
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein.
Zhang ZX; Chen M; Wallhagen K; Trojnar J; Magnius LO; Wahren B; Sällberg M
Clin Exp Immunol; 1994 Jun; 96(3):403-9. PubMed ID: 7516270
[TBL] [Abstract][Full Text] [Related]
10. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees.
Wang YF; Brotman B; Andrus L; Prince AM
J Infect Dis; 1996 Apr; 173(4):808-21. PubMed ID: 8603958
[TBL] [Abstract][Full Text] [Related]
11. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to recombinant and synthetic peptides derived from the hepatitis C virus genome in long-term-studied patients with posttransfusion hepatitis C.
Mattsson L; Gutierrez RA; Dawson GJ; Lesniewski RR; Mushahwar LK; Weiland O
Scand J Gastroenterol; 1991 Dec; 26(12):1257-62. PubMed ID: 1722348
[TBL] [Abstract][Full Text] [Related]
13. Lack of anti-GOR antibody among subjects with GB virus C/hepatitis G virus RNA.
Nakano T; Mizokami M; Cao K; Noguchi S; Sata M; Park YM; Kim BS; Oyunsuren T; Pereira LB; Ruzibakiev R; Gurtsevitch V; Hayami M
J Med Virol; 1998 Jun; 55(2):129-33. PubMed ID: 9598933
[TBL] [Abstract][Full Text] [Related]
14. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
Bååth L; Widell A
Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
[No Abstract] [Full Text] [Related]
15. A sensitive serodiagnosis of hepatitis C virus (HCV) infection with two non-fused peptides: comparison of antibody responses detected with a newly developed assay and a commercial second-generation test.
Sato A; Ida N; Ishikawa M; Tanahashi K; Nakamura H; Sho Y; Arima T; Kunitomo T
Microbiol Immunol; 1993; 37(4):295-304. PubMed ID: 7688847
[TBL] [Abstract][Full Text] [Related]
16. Anti-GOR and hepatitis C virus in autoimmune liver diseases.
Michel G; Ritter A; Gerken G; Meyer zum Büschenfelde KH; Decker R; Manns MP
Lancet; 1992 Feb; 339(8788):267-9. PubMed ID: 1346282
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies.
Quiroga JA; Castillo I; Bartolomé J; Carreño V
Clin Vaccine Immunol; 2007 Oct; 14(10):1302-6. PubMed ID: 17699833
[TBL] [Abstract][Full Text] [Related]
18. [Detection of anti-HCV antibody, anti-GOR antibody and autoantibodies in sera of patients with non-A, non-B liver diseases].
Kobayashi T; Kaneko Y; Satoh J; Harada T; Yamada R
Rinsho Byori; 1992 Dec; 40(12):1297-302. PubMed ID: 1284916
[TBL] [Abstract][Full Text] [Related]
19. Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C.
Koskinas J; McFarlane BM; Nouri-Aria KT; Tibbs CJ; Mizokami M; Donaldson PT; McFarlane IG; Williams R
Gastroenterology; 1994 Nov; 107(5):1436-42. PubMed ID: 7523226
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of an anti-HCV core peptide ELISA.
Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
